---
id: infection-control-prevention_117
category: clinical_syndromes
tags: [infection-control, standard-precautions, isolation, hand-hygiene, PPE]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Infection Control & Prevention

**Q:** What are the core infection control practices, types of isolation precautions, hand hygiene principles, and key strategies for preventing healthcare-associated infections?

**A:**

## STANDARD PRECAUTIONS (TIER 1)

**Definition:** Minimum infection prevention practices that apply to **ALL patient care**, regardless of suspected or confirmed infection status

**Core Components:**

1. **Hand Hygiene** - before/after patient contact
2. **Personal Protective Equipment (PPE)** - gloves, gowns, masks, eye protection (based on anticipated exposure)
3. **Respiratory Hygiene/Cough Etiquette** - cover coughs, mask symptomatic patients
4. **Safe Injection Practices** - one needle/syringe per injection
5. **Safe Handling of Sharps** - sharps containers, no recapping
6. **Environmental Cleaning** - routine cleaning/disinfection

**Key Point:** **Standard precautions = universal** (apply to ALL patients)

---

## TRANSMISSION-BASED PRECAUTIONS (TIER 2)

**Add to standard precautions** when patient has known/suspected infection with epidemiologically important pathogens

### **1. CONTACT PRECAUTIONS**

**Transmission:** Direct/indirect contact with patient or environment

**PPE:** **Gown + Gloves** (on entry to room)

**Pathogens:**
- **MDRO:** MRSA, VRE, CRE, MDR Acinetobacter, MDR Pseudomonas
- **C. difficile** (use **soap and water** for hand hygiene - alcohol doesn't kill spores)
- **Scabies**
- **Norovirus, rotavirus** (gastroenteritis)
- **RSV, adenovirus** (infants/young children)

**Key Point:** **C. diff = contact precautions + soap and water** (alcohol ineffective against spores)

---

### **2. DROPLET PRECAUTIONS**

**Transmission:** Large respiratory droplets (>5 μm) - travel **<6 feet**

**PPE:** **Surgical mask** (on entry to room)

**Room:** Private room OR cohorting (no negative pressure required)

**Pathogens:**
- **Influenza, RSV, adenovirus, rhinovirus**
- **Pertussis** (Bordetella pertussis)
- **Meningococcal disease** (*Neisseria meningitidis*)
- **Mumps, rubella**
- **Diphtheria** (pharyngeal)
- **Mycoplasma pneumoniae**
- **Plague** (pneumonic)

**Key Point:** **Droplet = surgical mask** (large droplets, <6 feet)

---

### **3. AIRBORNE PRECAUTIONS**

**Transmission:** Small airborne particles (<5 μm) - remain suspended in air, travel **>6 feet**

**PPE:** **N95 respirator** (fit-tested) OR PAPR (powered air-purifying respirator)

**Room:** **Airborne infection isolation room (AIIR)** - negative pressure, ≥12 air changes/hour

**Pathogens:**
- **Tuberculosis** (pulmonary or laryngeal)
- **Measles** (rubeola)
- **Varicella** (chickenpox - primary or disseminated zoster)
- **SARS, MERS, COVID-19** (especially during aerosol-generating procedures)
- **Smallpox** (variola)

**Key Point:** **Airborne = N95 + negative pressure room** (TB, measles, varicella)

---

### **COMBINATION PRECAUTIONS**

**Droplet + Contact:**
- **Adenovirus** (pneumonia)
- **COVID-19** (use N95 if aerosol-generating procedure)

**Airborne + Contact:**
- **Varicella** (chickenpox, disseminated zoster)
- **Smallpox**

**Key Point:** **Varicella = airborne + contact** (disseminated zoster only if immunocompromised)

---

## HAND HYGIENE

**Mnemonic: "5 Moments for Hand Hygiene"**

1. **Before** touching a patient
2. **Before** clean/aseptic procedure
3. **After** body fluid exposure risk
4. **After** touching a patient
5. **After** touching patient surroundings

**Methods:**

| **Method** | **Agent** | **When to Use** |
|------------|-----------|-----------------|
| **Alcohol-based hand rub (ABHR)** | 60-95% alcohol | **Preferred for most clinical situations** (faster, more effective) |
| **Soap and water** | Antimicrobial or plain soap | **C. difficile, norovirus** (spore-forming organisms)<br>**Visibly soiled hands** |

**Key Point:** **Alcohol hand rub = preferred** (except C. diff, norovirus, visible soil → soap and water)

---

## DURATION OF ISOLATION BY PATHOGEN

| **Pathogen** | **Duration of Isolation** |
|--------------|---------------------------|
| **MRSA, VRE** | Until discharge OR 3 negative cultures (depends on institutional policy) |
| **C. difficile** | **Duration of diarrhea + 48 hours** after resolution |
| **Influenza** | **5 days** from symptom onset (7 days in immunocompromised) |
| **Varicella** | Until all lesions crusted |
| **Tuberculosis (pulmonary)** | Until 3 negative AFB smears OR **2 weeks of effective therapy + clinical improvement** |
| **N. meningitidis** | **24 hours** after effective antibiotic therapy |
| **Pertussis** | **5 days** after starting macrolide therapy OR **21 days** if untreated |

**Key Point:** **N. meningitidis = 24 hours of antibiotics** → discontinue droplet precautions

---

## PERSONAL PROTECTIVE EQUIPMENT (PPE)

**Donning Order (Put On):** **Gown → Mask/Respirator → Eye Protection → Gloves**

**Doffing Order (Remove):** **Gloves → Eye Protection → Gown → Mask/Respirator** (remove mask LAST - most contaminated)

**Key Point:** **Remove gloves first, mask last** (minimize self-contamination)

---

## PREVENTION OF HEALTHCARE-ASSOCIATED INFECTIONS (HAI)

### **1. CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION (CLABSI)**

**Prevention Bundle:**
- **Hand hygiene**
- **Maximal sterile barrier precautions** (full-body drape, cap, mask, sterile gown, sterile gloves)
- **Chlorhexidine skin antisepsis** (>0.5% concentration)
- **Optimal catheter site selection** (avoid femoral if possible - subclavian preferred)
- **Daily review of line necessity** (remove if not needed)

**Key Point:** **Chlorhexidine + maximal sterile barriers** (CLABSI prevention)

---

### **2. CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI)**

**Prevention:**
- **Limit catheter use** (only if indicated)
- **Insert using aseptic technique**
- **Maintain closed drainage system**
- **Remove catheter as soon as possible** (daily assessment)

**Key Point:** **Avoid unnecessary urinary catheters** (remove ASAP)

---

### **3. VENTILATOR-ASSOCIATED PNEUMONIA (VAP)**

**Prevention Bundle:**
- **Elevate head of bed 30-45°**
- **Daily sedation vacation + spontaneous breathing trial**
- **Oral care with chlorhexidine** (0.12% solution BID)
- **Peptic ulcer prophylaxis**
- **DVT prophylaxis**
- **Early extubation** (minimize intubation duration)

**Key Point:** **HOB 30-45° + oral chlorhexidine** (VAP prevention)

---

### **4. SURGICAL SITE INFECTION (SSI)**

**Prevention:**
- **Preoperative antibiotics** (within 1 hour of incision)
- **Clippers (not razors)** for hair removal
- **Normothermia** (maintain body temperature)
- **Glucose control** (target <200 mg/dL)
- **Chlorhexidine-alcohol skin prep** (preferred)

**Key Point:** **Preoperative antibiotics within 1 hour** + chlorhexidine skin prep

---

### **5. C. DIFFICILE INFECTION (CDI)**

**Prevention:**
- **Antimicrobial stewardship** (limit fluoroquinolones, clindamycin, cephalosporins)
- **Contact precautions** + **soap and water hand hygiene**
- **Environmental cleaning with sporicidal agent** (bleach 1:10 dilution)
- **Private room** (if available)

**Key Point:** **Bleach for environmental cleaning** (alcohol ineffective against C. diff spores)

---

## DISINFECTION & STERILIZATION

| **Level** | **Kills** | **Agents** | **Uses** |
|-----------|-----------|------------|----------|
| **Sterilization** | **ALL microorganisms** (including spores) | Autoclave (steam), ethylene oxide, hydrogen peroxide plasma | Surgical instruments, implants |
| **High-Level Disinfection** | **Most microorganisms** (including mycobacteria, some spores) | 2% glutaraldehyde, ortho-phthalaldehyde (OPA), 6% hydrogen peroxide | Endoscopes, bronchoscopes |
| **Intermediate-Level Disinfection** | **Vegetative bacteria, mycobacteria, most viruses, most fungi** | Alcohol 70%, chlorine, phenolics | Non-critical equipment (stethoscopes, BP cuffs) |
| **Low-Level Disinfection** | **Most bacteria, some viruses, some fungi** | Quaternary ammonium compounds | Environmental surfaces |

**Key Point:** **Critical items (enter sterile tissue) = sterilization** (autoclave)

---

## POST-EXPOSURE PROPHYLAXIS (PEP)

### **HIV PEP (Needlestick, Sexual Assault)**

**Timing:** **Within 72 hours** (ideally <2 hours)

**Regimen:**
- **Tenofovir DF/emtricitabine (Truvada)** 1 tablet PO daily x **28 days**
- **PLUS Dolutegravir** 50 mg PO daily OR **Raltegravir** 400 mg PO BID x 28 days

---

### **HBV PEP (Needlestick)**

**If source HBsAg+:**
- **HBIG** 0.06 mL/kg IM x 1 dose (within 24 hours)
- **Hepatitis B vaccine series** (if not immune)

---

### **Rabies PEP (Animal Bite)**

**High-Risk Exposure (Bat, Raccoon, Skunk, Fox):**
- **Rabies immune globulin (RIG)** 20 IU/kg (infiltrate around wound + remaining IM)
- **Rabies vaccine** (days 0, 3, 7, 14)

---

**Clinical Pearls:**
- **Standard precautions = apply to ALL patients** (hand hygiene, PPE, safe sharps)
- **C. diff = contact precautions + soap and water** (alcohol ineffective)
- **Droplet = surgical mask** (influenza, pertussis, meningococcus)
- **Airborne = N95 + negative pressure** (TB, measles, varicella)
- **Varicella = airborne + contact** (disseminated zoster)
- **Hand hygiene: Alcohol hand rub preferred** (except C. diff, norovirus, visible soil)
- **CLABSI prevention: Chlorhexidine + maximal sterile barriers**
- **CAUTI prevention: Avoid unnecessary catheters, remove ASAP**
- **VAP prevention: HOB 30-45° + oral chlorhexidine**
- **Doffing PPE: Remove gloves first, mask last**
- **HIV PEP within 72 hours** (Truvada + dolutegravir x 28 days)

**Media:** None

**Sources:** [CDC 2024 - Core infection control practices], [CDC 2024 - Isolation precautions update]
